UK launches booster COVID vaccine study as B1.617.2 variant cases rise
The Cov-Boost study will trial seven vaccines to provide data on the impact of a third dose on patients immune responses.
Share Via Email
| A+A A- By PTI
LONDON: Thousands of volunteers will receive a booster COVID-19 vaccine in a new clinical trial launching on Wednesday to study the impact of the third jab to protect against the deadly virus, UK Health Secretary Matt Hancock has announced.
The Cov-Boost study will trial seven vaccines to provide data on the impact of a third dose on patients immune responses, as Britain confirmed 2,967 cases of the B1.617.2 variant first discovered in India up from the 2,323 on Monday.
Inician pruebas de tercera dosis de vacuna del covid-19 en Reino Unido ante temor por las variantes del virus
elobservador.com.uy - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from elobservador.com.uy Daily Mail and Mail on Sunday newspapers.
Vacunados contra Covid-19 mayoría de adultos en Reino Unido
prensa-latina.cu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prensa-latina.cu Daily Mail and Mail on Sunday newspapers.